Literature DB >> 5794069

Transport of gold in the body.

E G McQueen, P W Dykes.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5794069      PMCID: PMC1010514          DOI: 10.1136/ard.28.4.437

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

2.  Radioactive gold in filter paper electrophoresis patterns of plasma.

Authors:  N SIMON
Journal:  Science       Date:  1954-01-15       Impact factor: 47.728

3.  Studies with radioactive gold.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

4.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

5.  Displacement of one drug by another from carrier or receptor sites.

Authors:  B B Brodie
Journal:  Proc R Soc Med       Date:  1965-11

6.  The effect of gold salt on lysosomal enzymes of the peritoneal macrophage.

Authors:  R H Persellin; M Ziff
Journal:  Arthritis Rheum       Date:  1966-02

7.  [Physicochemical and biological studies on sulfonamides. 1. Pharmacologically interesting physicochemical characteristics of 21 sulfonamides and 6 sulfonamide metabolites].

Authors:  J RIEDER
Journal:  Arzneimittelforschung       Date:  1963-02
  7 in total
  16 in total

Review 1.  Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?

Authors:  E Jellum; J Aaseth; E Munthe
Journal:  Proc R Soc Med       Date:  1977

2.  Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.

Authors:  C J Danpure; D A Fyfe; J M Gumpel
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

3.  A comparison of tissue gold levels in guinea-pigs after treatment with myocrisin injected intramuscularly and triethylphosphine gold chloride and myocrisin administered orally.

Authors:  H Kamel; D H Brown; J M Ottaway; W E Smith; J Cottney; A J Lewis
Journal:  Agents Actions       Date:  1978-10

Review 4.  Clinical pharmacokinetics of oral and injectable gold compounds.

Authors:  K L Blocka; H E Paulus; D E Furst
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 5.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

6.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

7.  Metabolism of intracellular zinc and copper following single and repeated injections of gold sodium thiomalate.

Authors:  R P Sharma
Journal:  Agents Actions       Date:  1983-06

8.  Gold binding to blood cells and serum proteins during chrysotherapy.

Authors:  R J van de Stadt; B Abbo-Tilstra
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  Binding of sodium [195Au]aurothiomalate to Mycoplasma arthritidis.

Authors:  H L Talbot; D B Myers
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Role of metallothionein in cellular uptake and disposition of gold sodium thiomalate.

Authors:  R P Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.